Lenington Rachel 4
4 · Athira Pharma, Inc. · Filed Nov 5, 2021
Insider Transaction Report
Form 4
Lenington Rachel
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-03+150,000→ 150,000 totalExercise: $15.34Exp: 2031-11-02→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option vest on June 14, 2022 and one-fourth of the shares subject to the option vest on each subsequent anniversary thereafter.